VirtPrex Prenatal/Postnatal Tablets recalled over manufacturing violations
- Recall date
- December 12, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- VIRTUS PHARMACEUTICALS OPCO II L recalls VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle…
- Recall number
- D-0241-2017
- FDA classification
- Class III
- Brand / firm
- VIRTUS PHARMACEUTICALS OPCO II L
- Sold / distributed
- Nationwide
Why it was recalled
cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-348-30
Get recall alerts
Free email alert whenever VIRTUS PHARMACEUTICALS OPCO II L has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: VIRTUS PHARMACEUTICALS OPCO II L